Nianli Liu
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 03, 2024
METTL3-Mediated m6A Modification Regulates the Polycomb Repressive Complex 1 Components BMI1 and RNF2 in Hepatocellular Carcinoma Cells.Weina Chen, Jinqiang Zhang, Wenbo Ma
|Oct 16, 2024
RABIF promotes hepatocellular carcinoma progression through regulation of mitophagy and glycolysis.Ning Feng, Rui Zhang, Xin Wen
|Jan 16, 2023
Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma.Wei Wang, Rui Zhang, Ning Feng
|Aug 21, 2022
Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker.Rui Zhang, Wei Wang, Nie Zhang
|Apr 09, 2021
SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer.Nianli Liu, Aoxing Chen, Ning Feng
|Oct 29, 2020
MBD2 Correlates with a Poor Prognosis and Tumor Progression in Renal Cell Carcinoma.Liantao Li, Na Li, Nianli Liu
Pageof 2
